Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

LONDON, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its shares up nearly 9%.

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

The news was taken as a signal that Novo Nordisk's efforts to ramp up supplies of Wegovy and diabetes drug Ozempic are paying off. Also in October, a study showed that Ozempic could reduce the ...

Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its ...